EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy

Xiaojing Qin, Wenjing Ning, Han Liu, Xue Liu, Wenxin Luo, Ningshao Xia

Acta Pharmaceutica Sinica B · 2024-06 · 14 (6) · 2361-2377

DOI: 10.1016/j.apsb.2024.03.027 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-06. Verfasst von Xiaojing Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen 361102,…. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Planning Project of Guangdong Province, National Postdoctoral Program for Innovative Talents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Bispecific antibody (BsAbs)Cancer immunotherapyCombination therapy strategiesCytokine release syndromeT-cell redirecting BsAbsToxicityTumor microenvironmentTumor-associated antigens

Autor:innen und Institutionen

  • State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen 361102, China.
  • National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration…

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Planning Project of Guangdong Province
  • National Postdoctoral Program for Innovative Talents
  • Chinese Academy of Meteorological Sciences
  • China Postdoctoral Science Foundation

Zitieren

APA

Qin, X., Ning, W., Liu, H., Liu, X., Luo, W., & Xia, N. (2024). Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy. Acta Pharmaceutica Sinica B, 14(6), 2361-2377. https://doi.org/10.1016/j.apsb.2024.03.027

Vancouver

Qin X, Ning W, Liu H, Liu X, Luo W, Xia N. Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy. Acta Pharmaceutica Sinica B. 2024;14(6):2361-2377. doi:10.1016/j.apsb.2024.03.027

BibTeX
@article{Qin2024,
  author = {Qin, Xiaojing and Ning, Wenjing and Liu, Han and Liu, Xue and Luo, Wenxin and Xia, Ningshao},
  title = {Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2024},
  volume = {14},
  number = {6},
  pages = {2361--2377},
  doi = {10.1016/j.apsb.2024.03.027}
}
Kostenlos starten →